134 related articles for article (PubMed ID: 10850358)
1. A revolution in the treatment of non-Hodgkin's lymphoma.
DeNardo GL; O'Donnell RT; Oldham RK; DeNardo SJ
Cancer Biother Radiopharm; 1998 Aug; 13(4):213-23. PubMed ID: 10850358
[TBL] [Abstract][Full Text] [Related]
2. Antibody therapy in non-Hodgkin's lymphoma: the role of rituximab, 90Y-ibritumomab tiuxetan, and alemtuzumab.
Fietz T; Thiel E
Recent Results Cancer Res; 2007; 176():153-63. PubMed ID: 17607923
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas.
Lim SH; Marcus RE
Blood Rev; 1992 Sep; 6(3):157-62. PubMed ID: 1422284
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
Kaminski MS; Armitage JO
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-54-8. PubMed ID: 23570101
[No Abstract] [Full Text] [Related]
5. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
Maloney DG; Press OW
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy of Non-Hodgkin's lymphoma.
Britton KE
J Nucl Med; 2004 May; 45(5):924-5. PubMed ID: 15136647
[No Abstract] [Full Text] [Related]
7. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa.
Shome D; Esmaeli B
Curr Opin Ophthalmol; 2008 Sep; 19(5):414-21. PubMed ID: 18772675
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
Coiffier B
Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
[No Abstract] [Full Text] [Related]
9. Biokinetics and dosimetry of 188Re-anti-CD20 in patients with non-Hodgkin's lymphoma: preliminary experience.
Torres-García E; Ferro-Flores G; Arteaga de Murphy C; Correa-González L; Pichardo-Romero PA
Arch Med Res; 2008 Jan; 39(1):100-9. PubMed ID: 18068002
[TBL] [Abstract][Full Text] [Related]
10. Durable responses reported with radioimmunotherapy in low-grade non-Hodgkin's lymphoma.
Oncology (Williston Park); 2002 Mar; 16(3):304, 326. PubMed ID: 15046389
[No Abstract] [Full Text] [Related]
11. Myelosuppressive side-effects of radioimmunotherapy of non-Hodgkin's lymphoma: is there an increased risk?
Otte A; Dierckx RA
Nucl Med Commun; 2005 Dec; 26(12):1045-7. PubMed ID: 16264349
[No Abstract] [Full Text] [Related]
12. A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy.
Bishton MJ; Hicks RJ; Westerman DA; Prince MH; Wolf M; Seymour JF
Haematologica; 2008 May; 93(5):789-90. PubMed ID: 18450737
[No Abstract] [Full Text] [Related]
13. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary.
Bischof Delaloye A; Conti PS; Gisselbrecht C; Gregory SA
Oncologist; 2009; 14 Suppl 2():52-4. PubMed ID: 19819924
[No Abstract] [Full Text] [Related]
14. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: moving targets.
van Oers MH
Neth J Med; 2009 Sep; 67(8):309-10. PubMed ID: 19767656
[No Abstract] [Full Text] [Related]
15. Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
Appelbaum FR
Hematol Oncol Clin North Am; 1991 Oct; 5(5):1013-25. PubMed ID: 1938754
[TBL] [Abstract][Full Text] [Related]
16. The expanding frontier of radioimmunotherapy of relapsed Non-hodgkin's lymphoma.
Kozuch P; Grossbard ML
Clin Lymphoma; 2000 Sep; 1(2):158-9. PubMed ID: 11707826
[No Abstract] [Full Text] [Related]
17. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
Long J; Versea L
Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic approaches to non-Hodgkin's lymphomas.
Lambert JF; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
[No Abstract] [Full Text] [Related]
19. Bexxar, iodine I 131 tositumomab, effective in long-term follow-up of non-Hodgkin's lymphoma.
Kaminski M
Cancer Biol Ther; 2007 Jul; 6(7):996-7. PubMed ID: 19358342
[No Abstract] [Full Text] [Related]
20. Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
Hendrix C
ONS News; 2006; 21(8 Suppl):19-20. PubMed ID: 16925135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
